Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes

Microbial Pathogenesis

Volumn 22, Issue 3, 1997, Pages 133-142

  Koehler, L ^a   Nettelnbreker, E ^a   Hudson, A P ^b   Ott, N ^a   Gerard H C ^b   Branigan, P J ^c   Schumacher, H R ^c   Drommer, W ^a   Zeidler, H ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chlamydia trachomatis; chlamydial lipopolysaccharide; persistent infection; primary rRNA transcripts

Indexed keywords

LIPOPOLYSACCHARIDE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS;

EID: 0030980418     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0103     Document Type: Article

References (40)

1. Levitt L, Barol J. The immunobiology ofChlamydia. Immunology Today. 8:1987;246-251.
2. Wollenhaupt J, Zeidler H. Chlamydia. EULAR Bulletin. 3:1990;72-77.
3. Keat A, Thomas B, Dixey J, Osborn M, Sonnex C, Taylor-Robinson D. Chlamydia. The Lancet. 1987;72-74.
4. Hammer M, Nettelnbreker E, Hopf S, Schmitz E, Poerschke K, Zeidler H. Chlamydial rRNA in the joint of patients withChlamydia. Clin Exp Rheumatol. 10:1992;63-66.
5. Taylor-Robinson D, Gibroy CB, Thomas BJ, Keat ACS. Detection ofChlamydia trachomatis. Lancet. 340:1992;81-82.
6. Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL. Amplification of plasmid and chromodome chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthritis. Arthritis Rheum. 38:1995;1005-1013.
7. Nanagara R, Feng L, Beutler A, Hudson AP, Schumacher HR. Alteration ofChlamydia trachomatis. Arthritis Rheum. 38:1995;1410-1417.
8. Ischikawa H, Ohno O, Yamaski K, Kuta S, Hirohata K. Arthritis presumably caused by Chlamydia in Reiter syndrome. J Bone Joint Surg. 1986;777-779.
9. Schumacher RH, Maggae S, Cherian PV, Sleckman J, Rothfuss S, Clayburne G, Siek M. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Arthritis Rheum. 31:1988;937-946.
10. Yong EC, Chi EY, Kuo CC. Differential antimicrobial activity of human mononuclear phagocytes against the human biovars ofChlamydia trachomatis. J Immunol. 139:1987;1297-1302.
11. Nakajo MN, Roblin PM, Hammerschlag MR, Smith P, Nowakowski M. Chlamydicidal activity of human alveolar macrophages. Infect Immun. 58:1990;3640-3644.
12. Manor E, Sarov I. Fate ofChlamydia trachomatis. Infect Immun. 54:1986;90-95.
13. Schmitz E, Nettelnbreker E, Zeidler H, Hammer M, Manor E, Wollenhaupt J. Intracellular persistence of chlamydial major outer membrane protein, lipopolysaccharide and rRNA after non-productive infection of human monocytes withChlamydia trachomatis. J Med Microbiol. 38:1993;278-285.
14. Rahman MU, Schumacher HR, Hudson AP. Recurrent arthritis in Reiter's syndrome: a function of inapparent chlamydial infection of the synovium? Sem Arthritis Rheum. 21:1992;259-266.
15. Beutler AM, Whittum-Hudson JA, Nanagara R, Schumacher HR, Hudson AP. Intracellular location of inapparently infecting chlamydia in synovial tissue from patients with Reiter's syndrome. Immunol Res. 13:1994;163-171.
16. Matsumoto A, Bessho H, Uehira K, Suda T. Macrophological studies of the association of mitochondria with chlamydial inclusions and the fusion of chlamydial inclusions. J Electron Microsc. 40:1991;356-363.
17. Baumann M, Brade L, Fasske E, Brade H. Staining of surface antigens ofChlamydia trachomatis. Infect Immun. 60:1990;4433-4438.
18. Karimi ST, Schloemer RH, Wilde III CE, Lipsitz EC, Francus T. Accumulation of chlamydial lipopolysaccharide antigen in the plasma membrane of infected cells. Infect Immun. 57:1989;1780-1785.
19. Rothermel CD, Schachter J, Lavrich P, Lipsitz EC, Francus T. Chlamydia trachomatis induced production of interleukin-1 by human monocytes. Infect Immun. 57:1989;2705-2711.
20. Ingalls RR, Rice PA, Qureshi N, Takayama K, Shin Lin J, Golenbock DT. The inflammatory cytokine response toChlamydia trachomatis. Infect Immun. 63:1995;3125-3130.
21. Zvillich M, Kol R, Riklis E. Induction of DNA strands scissions in HeLa cells by human polymorphonuclear leucocytes activated byChlamydia trachomatis. J General Microbiol. 134:1988;2405-2412.
22. Zvillich M, Sarov I. The persistence ofChlamydia trachomatis. J Gen Microbiol. 135:1989;95-104.
23. Nomura M, Gourse R, Baughman G. Regulation of the synthesis of ribosomes and ribosomal components. Annu Rev Biochem. 53:1984;75-117.
24. Engel JN, Ganem D. Chlamydial rRNA operons: gene organization and identification of putative tandem promoters. J Bacteriol. 169:1987;5678-5685.
25. Beatty WL, Morrison RP, Byrne GI. Reactivation of persistentChlamydia trachomatis. Infect Immun. 63:1995;199-205.
26. Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc Nat Acad Sci USA. 81:1984;908-912.
27. Shemer Y, Sarov I. Inhibition of Growth ofChlamydia trachomatis. Infect Immun. 48:1985;592-596.
28. Shemer Y, Sarov I. Chlamydia trachomatis. Byrne GI, Turvo J (ed). Interferon and non-viral pathogens. New York, Marcel Dekker. 1988;73-99.
29. Shemer-Avni Y, Wallach D, Sarov I. Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. Infect Immun. 57:1989;3484-3490.
30. Thomas SM, Garrity LF, Brandt CR, Schobert CS, Feng G-S, Taylor MW, Carlin JM, Byrne GI. IFN-γ-mediated antimicrobial response. J Immunol. 150:1993;5529-5534.
31. Gupta SL, Carlin JM, Pyati P, Dai W, Pfefferkorn ER, Murphy MJ. Antiparasitic and antiproliferative effect of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect Immun. 62:1994;2277-2284.
32. Beatty WL, Belanger TA, Desal AA, Morrison RP, Byrne GI. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun. 62:1994;3705-3711.
33. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon γ-mediated persistentChlamydia trachomatisin vitro. Proc Natl Acad Sci USA. 90:1993;3998-4002.
34. Rasmussen SJ, Timms P, Beatty PR, Stephens RS. Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected withChlamydia. Infect Immun. 64:1996;1944-1949.
35. Nettelnbreker E, Bonk C, Zeidler H, Koehler L. IFN-mediated persistence of C. trachomatis serovar K is reversible with tryptophan but not in monocytic THP-1 cells. Proceedings of the European Chlamydia MeetingSocieta Edirice Esculapio, Italy. 1996;860.
36. Coles AM, Reynolds DJ, Harper A. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis. Microbiol Lett. 106:1993;193-200.
37. Caldwell H, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein ofChlamydia trachomatis. Infect Immun. 31:1981;1161-1176.
38. Rahman MU, Cheema MA, Schumacher HR, Hudson AP. Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum. 35:1992;521-529.
39. Sambrook, J, Fritsch, EF, Maniatis, T. 1989, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
40. Taylor HR, Agarwala N, Johnson SL. Detection of experimentalChlamydia trachomatis. J Clin Microbiol. 20:1984;391-395.